• SPX
  • $5,917.11
  • 0 %
  • $0.13
  • DJI
  • $43,408.47
  • 0.32 %
  • $139.53
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,117.63
  • 0.4 %
  • $32.56
  • IXIC
  • $18,966.14
  • -0.11 %
  • -$21.33
United-Guardian, Inc. (UG) Stock Price, News & Analysis

United-Guardian, Inc. (UG) Stock Price, News & Analysis

Currency in USD Disclaimer

$9.69

-$0.32

(-3.2%)

Day's range
$9.69
Day's range
$10.17
50-day range
$9
Day's range
$16.25
  • Country: US
  • ISIN: US9105711082
52 wk range
$6.75
Day's range
$16.25


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score N/A
  • Piotroski Score 5.00
  • Grade N/A
  • Symbol (UG)
  • Company United-Guardian, Inc.
  • Price $9.69
  • Changes Percentage (-3.2%)
  • Change -$0.32
  • Day Low $9.69
  • Day High $10.17
  • Year High $16.25

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.

  • Last Earnings 07/10/2024
  • Ex-Dividend for 5/16 Dividend 07/23/2024
  • Dividend Payable 07/31/2024
  • Today N/A
  • Next Earnings (Estimated) 03/14/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $0.60
  • Trailing P/E Ratio 14.77
  • Forward P/E Ratio 14.77
  • P/E Growth 14.77
  • Net Income $2.58 M

Income Statement

Quarterly

Annual

Latest News of UG

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

United-Guardian, Inc. Frequently Asked Questions

  • What is the United-Guardian, Inc. stock price today?

    Today's price of United-Guardian, Inc. is $9.69 — it has decreased by -3.2% in the past 24 hours. Watch United-Guardian, Inc. stock price performance more closely on the chart.

  • Does United-Guardian, Inc. release reports?

    Yes, you can track United-Guardian, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the United-Guardian, Inc. stock forecast?

    Watch the United-Guardian, Inc. chart and read a more detailed United-Guardian, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is United-Guardian, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by United-Guardian, Inc. stock ticker.

  • How to buy United-Guardian, Inc. stocks?

    Like other stocks, UG shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is United-Guardian, Inc.'s EBITDA?

    United-Guardian, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in United-Guardian, Inc.’s financial statements.

  • What is the United-Guardian, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.2371459329, which equates to approximately 23.71%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in United-Guardian, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including United-Guardian, Inc.'s financials relevant news, and technical analysis. United-Guardian, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for United-Guardian, Inc. stock currently indicates a “sell” signal. For more insights, review United-Guardian, Inc.’s technical analysis.

  • A revenue figure for United-Guardian, Inc. for its last quarter?

    United-Guardian, Inc. published it's last quarterly revenues at $3.06 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.